SCHEMBL803946

SCHEMBL803946

CN(Cc1ccccc1)C1CCN(c2ccc3cnccc3c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP2D6 P10635 1/20 0.45
CHRM1 P11229 1/20 0.45
HRH1 P35367 1/20 0.45
ROCK1 Q13464 4/20 0.44
ROCK2 O75116 1/20 0.44
CNR1 P21554 1/20 0.42
CNR2 P34972 1/20 0.42
MCHR1 Q99705 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
MMP2 P08253 1/20 0.40
MMP13 P45452 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
HTR1D P28221 4/20 0.39
HTR1B P28222 4/20 0.39
CHIA Q9BZP6 1/20 0.39
RORC P51449 1/20 0.39
PHGDH O43175 1/20 0.39
GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10274785 0.82 PHGDH (0.45) HRH3PHGDH
SCHEMBL1705004 0.78 ROCK1 (0.57) KDM4EALDH1A1ROCK1ROCK2GRIN2B
SCHEMBL1705001 0.78 ROCK1 (0.57) KDM4EALDH1A1ROCK1ROCK2GRIN2B
SCHEMBL1705239 0.78 ROCK1 (0.57) KDM4EALDH1A1ROCK1ROCK2GRIN2B
SCHEMBL803457 0.77 CYP2D6 (0.50) KDM4EALDH1A1CYP2D6CHRM1HRH1
SCHEMBL7310386 0.74 MCHR1 (0.50) KDM4EALDH1A1CYP2D6CHRM1HRH1
SCHEMBL5543151 0.73 MCHR1 (0.48) KDM4EALDH1A1CYP2D6CHRM1HRH1
SCHEMBL785912 0.73 CHRNB2 (0.47) KDM4EALDH1A1CYP2D6CHRM1HRH1
SCHEMBL803705 0.72 F10 (0.43) MMP2MMP13ADAMTS5PHGDH
SCHEMBL31520724 0.72 MCHR1 (0.42) KDM4EALDH1A1CYP2D6CHRM1HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 KDM4E 2727/4885ALDH1A1 1267/4885CYP2D6 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.